Expression of vascular endothelial growth factor in retinoblastoma

Archives of Ophthalmology

Volumn 128, Issue 2, 2010, Pages 223-229

  Areán, Carolina ^a   Orellana, Maria E ^a,b   Abourbih, Daniel ^b   Abreu, Carmen ^a   Pifano, Imelda ^a   Burnier Jr , Miguel N ^b  

^a UNIVERSIDAD CENTRAL DE VENEZUELA   (Venezuela)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

VASCULOTROPIN;

ADULT; ANTERIOR EYE CHAMBER; APOPTOSIS; ARTICLE; BASOPHIL; BLOOD VESSEL WALL; CANCER CLASSIFICATION; CANCER GROWTH; CANCER INVASION; CANCER SURGERY; CHOROID; DISEASE SEVERITY; ENUCLEATION; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; MITOSIS; OPTIC NERVE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; RETINOBLASTOMA; RETROSPECTIVE STUDY; STAINING; TUMOR DIFFERENTIATION; VITREOUS BODY;

APOPTOSIS; CELL DIFFERENTIATION; CHILD, PRESCHOOL; DISEASE PROGRESSION; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MITOTIC INDEX; NEOPLASM INVASIVENESS; NEOPLASM STAGING; NEOVASCULARIZATION, PATHOLOGIC; RETINAL NEOPLASMS; RETINOBLASTOMA; RETROSPECTIVE STUDIES; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 76349086679     PISSN: 00039950     EISSN: 15383601     Source Type: Journal    
DOI: 10.1001/archophthalmol.2009.386     Document Type: Article

References (24)

1. Howarth C, Meyer D, Hustu HO, Johnson WW, Shanks E, Pratt C. Stage-related combined modality treatment of retinoblastoma: results of a prospective study. Cancer. 1980;45(5):851-858.
2. Hurwitz RL, Shields CLSJ, Chevez-Barrios P, Chintagumpala MM. Retinoblastoma. In: Pizzo PA, Poplack DG, eds. Principles & Practice of Pediatric Oncology. 5th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2005:865-886.
3. Abramson DH. Retinoblastoma in the 20th century: past success and future challenges: the Weisenfeld lecture. Invest Ophthalmol Vis Sci. 2005;46(8):2683-2691.
4. Leal-Leal C, Flores-Rojo M, Medina-Sansón A, et al. A multicentre report from the Mexican Retinoblastoma Group. Br J Ophthalmol. 2004;88(8):1074-1077.
5. Font RL, Croxatto JO. Tumors of the Retina. Bethesda, MD: American Registry of Pathology; 2007.
6. Melamud A, Palekar R, Singh A. Retinoblastoma. Am Fam Physician. 2006;73(6): 1039-1044.
7. Harbour JW. Eye cancer: unique insights into oncogenesis: the Cogan Lecture. Invest Ophthalmol Vis Sci. 2006;47(5):1736-1745.
8. Burnier MN, McLean IW, Zimmerman LE, Rosenberg SH. Retinoblastoma: the relationship of proliferating cells to blood vessels. Invest Ophthalmol Vis Sci. 1990;31(10):2037-2040.
9. Rosenblatt MI, Azar DT. Anti-angiogenic therapy: prospects for treatment of ocular tumors. Semin Ophthalmol. 2006;21(3):151-160.
10. Khelfaoui F, Validire P, Auperin A, et al. Histopathologic risk factors in retinoblastoma: a retrospective study of 172 patients treated in a single institution. Cancer. 1996;77(6):1206-1213.
11. Grabowski EF, Abramson DH. Intraocular and extraocular retinoblastoma. Hematol Oncol Clin North Am. 1987;1(4):721-735.
12. de Souza Filho JP, Martins MC, Torres VL, et al. Histopathologic findings in retinoblastoma [in Portuguese]. Arq Bras Oftalmol. 2005;68(3):327-331.
13. Sang DN, Albert DM. Retinoblastoma: clinical and histopathologic features. Hum Pathol. 1982;13(2):133-147.
14. Shields CL, Shields JA, Baez KA, Cater J, De Potter PV. Choroidal invasion of retinoblastoma: metastatic potential and clinical risk factors. Br J Ophthalmol. 1993;77(9):544-548.
15. Marback EF, Arias VE, Paranhos A Jr, Soares FA, Murphree AL, Erwenne CM. Tumour angiogenesis as a prognostic factor for disease dissemination in retinoblastoma. Br J Ophthalmol. 2003;87(10):1224-1228.
16. Chang CY, Chiou TJ, Hwang B, Bai LY, Hsu WM, Hsieh YL. Retinoblastoma in Taiwan: survival rate and prognostic factors. Jpn J Ophthalmol. 2006;50(3): 242-249.
17. Benguigui ABM, Garabito Z, Ramirez G, Arévalo I, Suarez A. Retinoblastoma: report of ophthalmic oncology consultation at Francisco Antonio Rísquez Hospital between April 1992 and September 1995 [in Spanish]. Rev Oftalmol Venez. 1998; 54(3):43-50.
18. Biswas J, Das D, Krishnakumar S, Shanmugam MP. Histopathologic analysis of 232 eyes with retinoblastoma conducted in an Indian tertiary-care ophthalmic center. J Pediatr Ophthalmol Strabismus. 2003;40(5):265-267.
19. Jockovich ME, Piña Y, Alegret A, Cebulla C, Feuer W, Murray TG. Heterogeneous tumor vasculature in retinoblastoma: implications for vessel targeting therapy. Retina. 2008;28(3)(suppl):S81-S86.
20. Lee SY, Kim DK, Cho JH, Koh JY, Yoon YH. Inhibitory effect of bevacizumab on the angiogenesis and growth of retinoblastoma. Arch Ophthalmol. 2008;126 (7):953-958.
21. Stitt AW, Simpson DA, Boocock C, Gardiner TA, Murphy GM, Archer DB. Expression of vascular endothelial growth factor (VEGF) and its receptors is regulated in eyes with intra-ocular tumours. J Pathol. 1998;186(3):306-312.
22. Montero E, Abreu C, Tonino P. Relationship between VEGF and p53 expression and tumor cell proliferation in human gastrointestinal carcinomas. J Cancer Res Clin Oncol. 2008;134(2):193-201.
23. Kerimoǧglu H, Kiratli H, Dinçtürk AA, Söylemezoǧlu F, Bilgiç S. Quantitative analysis of proliferation, apoptosis, and angiogenesis in retinoblastoma and their association with the clinicopathologic parameters. Jpn J Ophthalmol. 2003;47 (6):565-571.
24. Murphree MS, Harbour JW. Tumors of the retina. In: Ryan SJ, ed. Retina. Philadelphia, PA: Elsevier/Mosby Publishing; 2006:557-607.